Memorializing Governor Kathy Hochul to proclaim February 19, 2026, as Cholangiocarcinoma Day in the State of New York
Impact
By designating a specific day for Cholangiocarcinoma awareness, this bill seeks to improve public knowledge of the disease and its implications. Increased awareness is critical, as the survival rate for this cancer is notably low, with a five-year survival rate of approximately 20%. This resolution aligns with global efforts recognizing World Cholangiocarcinoma Day, thereby contributing to a broader movement focused on advocacy and support for rare cancer research and treatment.
Summary
Bill K01003 is a resolution that aims to memorialize Governor Kathy Hochul to proclaim February 19, 2026, as Cholangiocarcinoma Day in the State of New York. The bill highlights the importance of raising awareness about Cholangiocarcinoma, a rare and lethal cancer affecting an estimated 10,000 people annually in the United States. It emphasizes the urgency of recognition and support for individuals impacted by the disease, including patients and caregivers.
Contention
The resolution may not have significant points of contention, as it primarily serves to increase awareness rather than enact new laws or regulations. However, discussions surrounding it could involve debates on the allocation of resources for cancer research and the prioritization of rare diseases in legislative agendas. The bill underscores the need for ongoing education about rare cancers and the efforts required to enhance research in this area. This highlights the importance of advocacy not just for Cholangiocarcinoma but for all rare cancers.
Vietnam Veterans Liver Fluke Cancer Study ActThis bill requires the Department of Veterans Affairs (VA) to conduct an epidemiological study and report on the prevalence of cholangiocarcinoma (bile duct cancer) in veterans who served in the Vietnam theater of operations during the Vietnam era. The study must identify the rate of incidence of cholangiocarcinoma in such veterans and in U.S. residents.The bill also requires the VA to track and report on the prevalence of cholangiocarcinoma using the Veterans Affairs Central Cancer Registry. Additionally, the VA must periodically submit follow-up reports to Congress regarding the epidemiological study and information collected from the cancer registry regarding the prevalence of bile duct cancer.